Changes in Hematologic Lab Measures Observed in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors, Ravulizumab and Eculizumab: Real-World Evidence from a US Based EMR Network
Fishman, J., Kuranz, S., Yeh, M. M., Brzozowski, K., & Chen, H. (2023). Changes in Hematologic Lab Measures Observed in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors, Ravulizumab and Eculizumab: Real-World Evidence from a US Based EMR Network. Hematology Reports, 15(2), 266-282. https://doi.org/10.3390/hematolrep15020027 View article Abstract Paroxysmal nocturnal hemoglobinuria (PNH), a rare acquired […]
Eltrombopag added to immunosuppression in severe aplastic anemia
Peffault de Latour R, Kulasekararaj A, Iacobelli S, et al. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia. N Engl J Med. 2022;386(1):11-23. doi:10.1056/NEJMoa2109965 View article Abstract Background: A single-group, phase 1-2 study indicated that eltrombopag improved the efficacy of standard immunosuppressive therapy that entailed horse antithymocyte globulin (ATG) plus cyclosporine in patients with severe […]